BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15139521)

  • 1. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.
    Qaddoumi MG; Ueda H; Yang J; Davda J; Labhasetwar V; Lee VH
    Pharm Res; 2004 Apr; 21(4):641-8. PubMed ID: 15139521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
    Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
    Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.
    Panyam J; Labhasetwar V
    Pharm Res; 2003 Feb; 20(2):212-20. PubMed ID: 12636159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
    Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
    Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of nanoparticle uptake by endothelial cells.
    Davda J; Labhasetwar V
    Int J Pharm; 2002 Feb; 233(1-2):51-9. PubMed ID: 11897410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.
    Panagi Z; Beletsi A; Evangelatos G; Livaniou E; Ithakissios DS; Avgoustakis K
    Int J Pharm; 2001 Jun; 221(1-2):143-52. PubMed ID: 11397575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.
    Desai MP; Labhasetwar V; Walter E; Levy RJ; Amidon GL
    Pharm Res; 1997 Nov; 14(11):1568-73. PubMed ID: 9434276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit.
    Horisawa E; Hirota T; Kawazoe S; Yamada J; Yamamoto H; Takeuchi H; Kawashima Y
    Pharm Res; 2002 Apr; 19(4):403-10. PubMed ID: 12033371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles.
    Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Livaniou E; Evangelatos G; Ithakissios DS
    Int J Pharm; 2003 Jun; 259(1-2):115-27. PubMed ID: 12787641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method.
    Xiong S; Zhao X; Heng BC; Ng KW; Loo JS
    Biotechnol J; 2011 May; 6(5):501-8. PubMed ID: 21259442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.
    Prabha S; Zhou WZ; Panyam J; Labhasetwar V
    Int J Pharm; 2002 Sep; 244(1-2):105-15. PubMed ID: 12204570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles.
    Oster CG; Wittmar M; Unger F; Barbu-Tudoran L; Schaper AK; Kissel T
    Pharm Res; 2004 Jun; 21(6):927-31. PubMed ID: 15212155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.
    Prabha S; Labhasetwar V
    Pharm Res; 2004 Feb; 21(2):354-64. PubMed ID: 15032319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
    Panyam J; Labhasetwar V
    Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity.
    Konan YN; Chevallier J; Gurny R; Allémann E
    Photochem Photobiol; 2003 Jun; 77(6):638-44. PubMed ID: 12870850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium.
    Bivas-Benita M; Romeijn S; Junginger HE; Borchard G
    Eur J Pharm Biopharm; 2004 Jul; 58(1):1-6. PubMed ID: 15207531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.